期刊文献+

酮洛芬对映异构体的计算机模拟

Computer Simulation Study on the Enantiomers of Ketoprofen
下载PDF
导出
摘要 采用Hyperchem8.0计算酮洛芬对映异构体的分子结构及能量,证明(S)-布洛芬的能量比(R)-酮洛芬略低。以(S)-酮洛芬为模板分子,4-乙烯吡啶(4-VP)、丙烯酰胺(AM)及α-甲基丙烯酸(MAA)为功能单体,模拟及探讨不同功能单体对酮洛芬的结合能,结果显示4-VP与模板分子所形成复合物的结合能较AM略大,模型稳定性和预测能力俱佳,为混旋酮洛芬的拆分打下了理论基础。 The optimal geometry configurations, energies of Ketoprofenwere simulated by Hyperchem8.0 software, the results indicated that the energy of S-Ketoprofenslightly below the R-Ketoprofen energy. A molecular simulation method for molecularly imprinted polymerization system using S-Ketoprofen as template and 4-vinyl pyridine (4-VP),methacrylicacid (MAA) and acrylicamide (AM) as functional monomers was presented. The optimal geometry configuration, energy, reaction ratio and binding energy of thepre-polymerization systems were simulated by a semi-empirical method (PM3) and Amber MM methods with Hyperchem8.0 software. The results show that MAA gives stronger bonding interaction with S-Ketoprofethan other monomer molecules studied. The model with good stability and predictability, and it provided valuable basic data for designing and optimizing treatment process.
机构地区 合肥工业大学
出处 《安徽化工》 CAS 2014年第1期14-16,共3页 Anhui Chemical Industry
基金 安徽省自然科学基金项目(编号:11040606M191)
关键词 酮洛芬 分子印迹聚合物 Hyperchem8 0 计算模拟 Ketoprofen molecularly imprinted polymers Hyperchem8.0 software computer simulation
  • 相关文献

参考文献5

二级参考文献33

  • 1孟子晖 王进防 等.-[J].色谱,1999,17(4):257-257.
  • 2Giunchedi P, Maggi L, Conte V, et al. Ketoprofen pnlsatile absorption from multiple unit hydrophilic matrixes[J]. Int J Pharm, 1991, 77(2 - 3): 177.
  • 3Miyoshi T, Mienmutsu H, Maruo A, et al. Transdermal preparations comprising flexible support layer and absorption enhancers in an adhesive layer:JP, 11 092361[P]1999 -02-01.
  • 4Yoshida M, Asaho M, Sawa T, et al. pH - responsive pharmaceutical gels: JP, 10 273 451 [P] 1998 - 10 - 13.
  • 5Finidori C. Buccal pharmaceutical compositions containing NSAIDs and ceramides for treating and preventing periodontal diseases: WO, 9720 572 [ P]1997 -06 - 12.
  • 6Mauleon D, Mis R, Ginesta J, et al. Pharmacokinetics of ketoprofen enantioners in monkeys following single and multiple oral administration [J ]. Chirality1994, 6: 537.
  • 7Mis R, Tost D, Ortega E, et al. Pharmacokinetics in plasma of oral 14C -LM - 1158, TRIS and 14C - R - ( - ) - ketoprofen in several species [J ]. 1993,Report codes: PK6/LM - 1158. TRIS/93; PK11/LM 1158, Tris/93.
  • 8Hayball PJ, Nution RL. Bochner F, et al. Plasma protein binding of ketoprofen enantiomers in man: method development and its application [J ]. Chirality,1991,3: 460.
  • 9Jamali F, Brocks DR. Clinical pharmacokinetics of ketoprofen and its enantiomer[J]. Clin Pharmacokinet, 1990, 19: 197.
  • 10Populaire P, Terlain B, Pascal S, et al. Biological behaviour: plasmatic levels,excretion and biotransformotion of 2 - (3 - benzoylphenyl ) propionic acid(ketoprofen)in animals and man[J]. Ann Pharm Fr, 1973, 31: 735.

共引文献69

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部